Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes
Response to Martin et al.
- David A. Mark, PHD
- From dmark consulting, Maynard, Massachusetts
- Address correspondence to David A. Mark, PhD, dmark consulting, 10 Maple St., Maynard, MA 01754. E-mail: david{at}dmarknutrition.com
In a recent article of Diabetes Care, Martin et al. (1) reported their findings of attenuation of weight gain in subjects with diabetes who were given 1,000 μg chromium in the form of chromium picolinate (CrPic) in combination with 5 mg glipizide, a sulfonylurea drug. Over the 24 weeks of cotherapy, the weight gain values were 0.0 and 1.3 kg for glipizide plus CrPic versus glipizide plus placebo, respectively.
From Fig. 2 of the article, it is apparent that all of the differences in body weight …
